-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Recursion Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q2 2024.
- Recursion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $16M, a 40.1% increase year-over-year.
- Recursion Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $63.5M, a 77.9% increase year-over-year.
- Recursion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $51.7M, a 92.3% increase from 2022.
- Recursion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $26.9M, a 94.3% increase from 2021.
- Recursion Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.8M, a 261% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)